Identification of Mycobacterium tuberculosis (MTB)-infection in immunocompromised hosts

M. Sester (Homburg, Germany)

Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)
Disease area: Respiratory infections

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Sester (Homburg, Germany). Identification of Mycobacterium tuberculosis (MTB)-infection in immunocompromised hosts. Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mycobacterium tilburgii infection in an HIV-seropositive host
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009


Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis
Source: Eur Respir J 2010; 35: 692-694
Year: 2010


Mycobacterium abscessus respiratory infection: importance in immunosuppressed patients
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008


Nontuberculous mycobacterial infections
Source: Eur Respir Mon 2011; 52: 115-129
Year: 2011


Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019


Identification of nontuberculous mycobacteria using GenoType® Mycobacterium CM
Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Year: 2010


Discriminating active from latent tuberculosis by Mycobacterium tuberculosis (MTB)-peptide specific immunoresponses
Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)
Year: 2008


Mycobacterium tuberculosis resistance
Source: Eur Respir J 2002; 20: Suppl. 38, 360s
Year: 2002

Clinical relevance of Mycobacterium malmoense isolation in the Netherlands
Source: Eur Respir J 2009; 34: 926-931
Year: 2009



Characteristics of mycobacterial strains isolated from immunocompetent and immunosuppressed patients with particular forms of tuberculosis
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007


Pulmonary diseases caused by non-tuberculous mycobacteria
Source: Eur Respir Mon 2012; 58: 25-37
Year: 2012


Latent tuberculosis in the nonimmunocompromised host
Source: Annual Congress 2006 - PG11 - Clinical highlights on tuberculosis
Year: 2006

Transmission of Mycobacterium tuberculosis to households of tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 197s
Year: 2005

On the nature of Mycobacterium tuberculosis-latent bacilli
Source: Eur Respir J 2004; 24: 1044-1051
Year: 2004



Community acquired pneumonia due to Mycobacterium tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 416s
Year: 2004

Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021
Year: 2022



Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis
Source: Eur Respir J 2010; 35: 338-342
Year: 2010



Invasive Mycobacterium avium intracellulare infection
Source: Eur Respir J 2006; 28: Suppl. 50, 312s
Year: 2006

Pneumonectomy in lung infections with Mycobacterium tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 459s
Year: 2001